Epitomee Medical
Caesarea
About Epitomee Medical
Epitomee develops paradigm-shifting ingestible devices that deploy targeted therapies along the GI tract. The company develops and commercializes ingestible therapeutic devices with the goal of addressing some of today's most common chronic diseases in a self-managed, safer, kinder to the system, and more manageable manner. Their technology is based on self-expanding hydro-gel scaffolds folded into a standard pharmaceutical capsule, produced from biocompatible excipients, food additives, and food contact materials.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $8.0M
- Funding stage: IPO
- Last round: Series A (Apr 2019)
- Ticker: tlv:EPIT
- Website: epitomeemedical.com
- Phone: +972.722.505.995
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/epitomee-medical-37974 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.